Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,718 | $30,136 | $63,201 | $108,921 |
| - Cash | $15,080 | $14,556 | $19,237 | $44,761 |
| + Debt | $2,143 | $2,965 | $4,344 | $4,264 |
| Enterprise Value | $21,781 | $18,545 | $48,308 | $68,424 |
| Revenue | $8,417 | $6,033 | $6,081 | $3,321 |
| % Growth | 39.5% | -0.8% | 83.1% | – |
| Gross Profit | $5,842 | $4,113 | $4,831 | -$8,586 |
| % Margin | 69.4% | 68.2% | 79.4% | -258.5% |
| EBITDA | -$16,580 | -$108,036 | -$49,022 | -$32,692 |
| % Margin | -197% | -1,790.8% | -806.2% | -984.4% |
| Net Income | -$17,119 | -$98,181 | -$50,790 | -$34,705 |
| % Margin | -203.4% | -1,627.4% | -835.2% | -1,045% |
| EPS Diluted | -1.36 | -8.35 | -4.8 | -3.86 |
| % Growth | 83.7% | -74% | -24.4% | – |
| Operating Cash Flow | -$2,916 | -$17,612 | -$24,108 | -$35,711 |
| Capital Expenditures | -$172 | -$446 | -$521 | -$13,708 |
| Free Cash Flow | -$3,088 | -$18,058 | -$24,629 | -$49,419 |